合并深静脉血栓形成对卵巢癌预后的影响(4)
[16] Chen LM，Wang W，Lee JC，et al. Thrombomodulin mediates the progression of epithelial ovarian cancer cells [J]. Tumour Biol，2013，34(6)：3743-3751.
[17] Yuan L，Liu X. Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism [J]. Mol Med Rep，2015，11(4)：2449-2458.
[18] Gunderson CC，Thomas ED，Slaughter KN，et al. The surv？鄄ival detriment of venous thromboembolism with epithelial ovarian cancer [J]. Gynecol Oncol，2014，134(1)：73-77.
[19] Diaz ES，Walts AE，Karlan BY，et al. Venous thromboe？鄄mbolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival [J]. Gynecol Oncol，2013，131(3)：541-545.
[20] Cohen JG，Prendergast E，Geddings JE，et al. Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer [J]. Gynecol Oncol，2017，146(1)：146-152.
[21] Abu SF，Norris L，O'Toole S，et al. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer-relationship with venous thrombosis risk [J]. Thromb Res，2013，132(5)：627-634.
[22] Oranratanaphan S，Termrungruanglert W，Khemapech N. Incidence and Clinical Characteristic of Venous Thromboembolism in Gynecologic Oncology Patients attending King Chulalongkorn Memorial Hospital over a 10 Year Period [J]. Asian Pac J Cancer Prev，2015，16(15)：6705-6709.
(收稿日期：2017-12-01 本文編辑：刘学梅), 百拇医药(胡月 唐冬)
[17] Yuan L，Liu X. Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism [J]. Mol Med Rep，2015，11(4)：2449-2458.
[18] Gunderson CC，Thomas ED，Slaughter KN，et al. The surv？鄄ival detriment of venous thromboembolism with epithelial ovarian cancer [J]. Gynecol Oncol，2014，134(1)：73-77.
[19] Diaz ES，Walts AE，Karlan BY，et al. Venous thromboe？鄄mbolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival [J]. Gynecol Oncol，2013，131(3)：541-545.
[20] Cohen JG，Prendergast E，Geddings JE，et al. Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer [J]. Gynecol Oncol，2017，146(1)：146-152.
[21] Abu SF，Norris L，O'Toole S，et al. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer-relationship with venous thrombosis risk [J]. Thromb Res，2013，132(5)：627-634.
[22] Oranratanaphan S，Termrungruanglert W，Khemapech N. Incidence and Clinical Characteristic of Venous Thromboembolism in Gynecologic Oncology Patients attending King Chulalongkorn Memorial Hospital over a 10 Year Period [J]. Asian Pac J Cancer Prev，2015，16(15)：6705-6709.
(收稿日期：2017-12-01 本文編辑：刘学梅), 百拇医药(胡月 唐冬)